Subject amtk aligned with baxter  nyse  bax   medtronic  nyse  mdt  and others
could soon bring huge profits to investors 
sleeper stock alert
amtk aligned with baxter  nyse  bax   medtronic  nyse  mdt  and others could soon bring huge profits to investors 
company 
stock symbol 
current price 
website 
industry 
success 
austin medical technologies  inc 
amtk
        
www  austinmedtech  com
healthcare  software
provides surgical products which perform over    surgeries per year
years in business   and years
sleeper stock alert seeks out little known  up and coming companies that are poised to break out of their trading patterns and reach new highs  we all know that no matter where the market heads  smart investors use these techniques to build ever growing fortunes  the company profiled today  amtk  is a perfect example of a company that we feel has such potential  by getting in early  savvy investor  s have the best chance of turning small investment  s into a fortune  sleeper stock alert feels that the clich the greater the risk the greater the reward holds true
business description  austin medical technologies  inc  uses the dell model to deliver the only single source supply solution of custom sterile procedure trays and medical devices through innovative technology and traditional sales channels dedicated exclusively to the outpatient surgery centers  asc  market  eyedireciti is a dominate brand in the ophthalmic market segment 
who do they sell to  the fastest growing segment of heath care  the outpatient surgery center  s  asc  s  performing  million surgeries per year representing a     billion dollar market  surgery  s such as  lasik  cataract  glaucoma and retinal surgery  plastic  orthopedic  ent  ob  gyn fertility  pain management  cardiology  oncology  dermatology  urology  and vascular surgery  the annual growth in this market is over   per year 
pain in this market  there is no single source supply solution in the market  therefore customers have high cost dealing with multiple suppliers  no technology to build and manage a pre  packaged device environment designed to deliver     of disposable surgical supply needs 
market potential  asc  s represent a     billion dollar market potential for products and services austin medtech delivers 
company background  successfully implemented the first technology based supply chain solution for ophthalmology that directly reduces overall operating cost for our customers  suppliers and partners  secured partnerships with    baxter healthcare  inc   nyse  bax  a world leader in health care manufacturing and   medtronic ophthalmic  nyse  mdt  a world leader in medical devices and   allergan  inc   nyse  agn  leading pharmaceutical company and   cynacon  ocusoft  inc  a leader in ophthalmic diagnostics 
management  for  years the ceo has held leading sales and management positions with allegiance    yrs  and maxxim    yrs  who collectively control   of the  billion dollar custom sterile pack market  the rest of the management team has proven track records 
uniqueness  intellectual property  ip   austin medical technologies  inc  has proprietary technology that is web  based to empower the customer to drive out cost  keep control and improve efficiencies 
strategic alliances  w ith baxter healthcare  inc  for manufacturing  and allergan  inc   a dedicated ophthalmic sales force in the us and canada 
customer acquisition historical and projected  annualized growth 
customer growth remains brisk and by leveraging partnerships the company has over  sales professionals representing its products and services 
in fact in a press release issued in july of this year the company went on to say sales from  were up   over  and sales for the lq of  were up   from the lq of  and sales for the  q of  were up   over the  q of   the company also stated that it signed several multi year contracts in the lq of this year  fortec onsight was added as a customer in the  q and signed  new multi year contracts in june  we believe this sleeper stock is just beginning to awaken 
disclaimer 
information within this email contains  forward looking statements  within the meaning of section  a of the securities act of  and section  b of the securities exchange act of   any statements that express or involve discussions with respect to predictions  goals  expectations  beliefs  plans  projections  objectives  assumptions or future events or performance are not statements of historical fact and may be  forward looking statements  
forward looking statements are based on expectations  estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated  forward looking statements in this action may be identified through the use of words such as   projects    foresee    expects    estimates    believes    understands   will    part of   anticipates   or that by statements indicating certain actions  may    could   or  might  occur  all information provided within this email pertaining to investing  stocks  securities must be understood as information provided and not investment advice  we advise all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in stocks featured within this email  none of the material within this report shall be construed as any kind of investment advice  please have in mind  that the interpretation of the witer of this newsletter about the news published by the company does not represent the company official statement and in fact may differ from the real meaning of what the news release meant to say  please read the news release by yourself and judge by yourself about the details in it 
readers of this publication are cautioned not to place undue reliance on forward  looking statements  which are based on certain assumptions and expectations involving various risks and uncertainties that could cause results to differ materially from those set forth in the forward  looking statements 
please be advised that nothing within this email shall constitute a solicitation or an offer to buy or sell any security mentioned herein  this newsletter is neither a registered investment advisor nor affiliated with any broker or dealer  all statements made are our express opinion only and should be treated as such  we may own  buy and sell any securities mentioned at any time  this report includes forward  looking statements within the meaning of the private securities litigation reform act of   these statements may include terms as  expect    believe    may    will    move  undervalued  and  intend  or similar terms  this newsletter was paid   froma third party to send this report  please do your own due diligence before investing in any profiled company  you may lose money from investing in penny stocks
austin medical technologies  inc   west park blvd   ste   plano  tx 
